Literature DB >> 25602994

Hematopoietic stem cell transplantation for MS: extraordinary evidence still needed.

Stephen L Hauser1.   

Abstract

Mesh：

Year:  2015        PMID： 25602994     DOI： 10.1001/jama.2014.18150

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  An Innovative, Comprehensive Mapping and Multiscale Analysis of Registered Trials for Stem Cell-Based Regenerative Medicine.

Authors:  Paul Monsarrat; Jean-Noel Vergnes; Valérie Planat-Bénard; Philippe Ravaud; Philippe Kémoun; Luc Sensebé; Louis Casteilla
Journal:  Stem Cells Transl Med       Date:  2016-04-13       Impact factor: 6.940

Review 2.  Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience.

Authors:  Daniela Currò; Gianluigi Mancardi
Journal:  Neurol Sci       Date:  2016-04-12       Impact factor: 3.307

Review 3.  Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part I. Targeting a metabolic model rather than autoimmunity.

Authors:  Susan J van Rensburg; Ronald van Toorn; Rajiv T Erasmus; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Merlisa C Kemp; Penelope Engel-Hills; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2021-04-28       Impact factor: 3.584
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.